First-generation GHSR-1a agonist. More potent appetite-stimulatory effect than GHRP-2 or ipamorelin — useful property when cachexia is a therapeutic target, a nuisance otherwise. Moderate cortisol/prolactin rise.
Half-Life & Elimination Curve (SC: 2.5h)
Elimination (SC)
0×t½0h100%
1×t½2.5h50%
2×t½5h25%
3×t½7.5h12.5%
4×t½10h6.3%
5×t½12.5h3.1%
Elimination t½2.5h (SC)
Rate Constant (ke)0.277 h⁻¹
97% Washout (5×t½)12.5h
Dosing Guidelines
Subcutaneous (SC): Typical 167 mcg (Range: 100–300 mcg)